Profluent Bio
AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.
About
Profluent Bio develops deep generative AI models to design and validate novel, functional proteins, enabling the programmatic authorship of new biological entities. Their platform aims to overcome traditional limitations in protein engineering by computationally modeling and validating specific protein structures and functions, providing precise control over biological function for applications in therapeutics, agriculture, and advanced materials.
Key facts
At-a-glance profile data
- Website
- profluent.bio
- Headquarters
- Emeryville, United States
- Founded
- 2022
- Employees
- 66
- Total funding
- $150M (Series A)
- Business model
- B2B
- Tags
- BiotechLife ScienceArtificial IntelligenceDrug DiscoveryGene Editing
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 20 Nov 2024 | Series A | $106M | Spark Capital, Nexus VP |
| 23 May 2023 | Undisclosed round | $35M | Insight Partners |
| 25 Jan 2022 | Undisclosed round | $9M | Air Street Capital, Lux Capital |
Tech stack
Detected on profluent.bio and in its job posts, last scanned 20 Aug 2026. Run your own scan
- Frontend
- Tailwind CSS, Bootstrap
- Backend
- Python
- Analytics
- Google Analytics 4
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Hosting
- Google Cloud, AWS, Azure
- Email provider
- Google Workspace
- Hiring platform
- Greenhouse
- Video / media
- Vimeo
Frequently asked
How much funding has Profluent Bio raised?
Profluent Bio has raised a total of $150M in funding. The most recent round on record is Series A.
How many employees does Profluent Bio have?
Profluent Bio has approximately 66 people on record.